South Africa clinical-trials pages explain research context, not treatment authority.

Clinical-trials content may explain research phases, evidence limitations, participant safety questions, ethics-review boundaries, source status, and medication research context. It must not tell users to join a trial, use a medicine, stop a medicine, or treat a condition.

Trial phase education

Evidence limitations

Participant safety questions

Ethics-review boundary

Source status

Medication research context

Trial phase education

Early phase

Early research may focus on safety, dose range, and biological activity. It is not proof that a medicine is right for a specific person.

Later phase

Later research may compare outcomes, side effects, and effectiveness, but trial context still does not equal personal treatment advice.

South Africa research and medication safety context

Clinical-trials pages should not imply treatment authority.

South Africa clinical-trials content may explain research phases, evidence limitations, participant safety questions, ethics-review boundaries, source status, and medication research context. It must not tell users to join a trial, use a medicine, stop a medicine, or treat a condition.

Disabled workflows

Trial enrollment: disabled

Clinical workflow: disabled

Patient-specific treatment instruction: disabled

AI-only prescribing: disabled

Final diagnosis: disabled

Final prescription: disabled

Provider matching: disabled

Eligibility decision: disabled

Related South Africa medication pages

South Africa medication hub →South Africa advisories →Compare Kenya medication context →Medication intelligence →

Governance marker

Content version: v0.2 premium South Africa medication clinical trials preview

Clinical workflow status: disabled

Trial enrollment workflow status: disabled